How much funding has Forge Biologics raised?

Forge Biologics has raised $250.0M in total funding, most recently a Series C round.

Who are Forge Biologics's investors?

Forge Biologics's investors include Drive Capital, Perceptive Advisors, Aisling Capital, RA Capital Management, Surveyor Capital.

When was Forge Biologics founded?

Forge Biologics was founded in 2020.

Where is Forge Biologics headquartered?

Forge Biologics is headquartered in Grove City, Ohio, United States.

What industry is Forge Biologics in?

Forge Biologics operates in Biotech, Healthcare.

How many employees does Forge Biologics have?

Forge Biologics has 51-200 employees.

Forge Biologics

Gene Therapy CDMO

Grove City, United States · Founded 2020 · $250.0M raised

Biotech

Healthcare

Headquarters: Grove City, Ohio
Employees: 51–200
Founded: 2020
Business Model: B2B

Website: forgebiologics.com
Total Funding: $250.0M
Last Round: $90.0M Series CJan 2024
Rounds: 3

About

Forge Biologics is a US-based gene therapy CDMO and member of the Ajinomoto Group, delivering comprehensive AAV manufacturing services from early development through clinical trials and commercial production. Founded in 2020 by gene therapy developers, Forge combines firsthand development expertise with deep AAV manufacturing capabilities to help therapy developers bring treatments from concept to patient.

Summary

Forge Biologics is a Biotech company based in Grove City, United States, founded in 2020. It has raised $250.0M in total across 3 rounds, most recently a $90.0M Series C round in Jan 2024. Investors include Drive Capital, Perceptive Advisors and Aisling Capital.

LinkedIn X (Twitter)